Queen Mary University of London
325
61
85
173
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
7.4%
24 terminated/withdrawn out of 325 trials
87.8%
+1.3% vs industry average
9%
30 trials in Phase 3/4
10%
18 of 173 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (325)
Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)
Role: lead
Psychosocial Support for Nitrous Oxide Misuse
Role: lead
Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study
Role: lead
Barts Endocarditis Research Registry
Role: lead
Effect of Implant Surface Material and Topography on Bone Regeneration.
Role: lead
Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs
Role: lead
Randomised Trial Comparing Thermal Ablation With Adrenalectomy in the Treatment of Unilateral Asymmetric PA
Role: lead
Longitudinal Population-based Observational Study of COVID-19 in the UK Population
Role: lead
Left Ventricular Thrombus Registry
Role: lead
Investigation of the Distinct Mechanisms Involved in Inflammatory Resolution Between Healthy Men and Women
Role: lead
The Growing Well Study
Role: collaborator
Foot Care in Care Homes
Role: collaborator
Autologous Platelet Concentrate (APC) in Intrabony Defects
Role: lead
Detection of Mycobacterium Tuberculosis in Blood of TB Patients and Their Contacts in Uganda
Role: lead
Hyaluronic Acid and Polynucleotides for Supra-bony Defects
Role: lead
Thromboprophylaxis in Lower Limb Immobilisation
Role: lead
Periodontal Assessment of a Bariatric Care Population
Role: lead
Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM)
Role: collaborator
Slow-SPEED UK: A Double-Blind Randomised Feasibility Trial
Role: lead
Minimally-invasive Non-surgical and Surgical Periodontitis Treatment
Role: lead